The mutation profile of SARS-CoV-2 is primarily shaped by the host antiviral defense
Abstract
Understanding SARS-CoV-2 evolution is a fundamental effort in coping with the COVID-19 pandemic. The virus genomes have been broadly evolving due to the high number of infected hosts world-wide. Mutagenesis and selection are the two inter-dependent mechanisms of virus diversification. However, which mechanisms contribute to the mutation profiles of SARS-CoV-2 remain under-explored. Here, we delineate the contribution of mutagenesis and selection to the genome diversity of SARS-CoV-2 isolates. We generated a comprehensive phylogenetic tree with representative genomes. Instead of counting mutations relative to the reference genome, we identified each mutation event at the nodes of the phylogenetic tree. With this approach, we obtained the mutation events that are independent of each other and generated the mutation profile of SARS-CoV-2 genomes. The results suggest that the heterogeneous mutation patterns are mainly reflections of host (i) antiviral mechanisms that are achieved through APOBEC, ADAR, and ZAP proteins and (ii) probable adaptation against reactive oxygen species. ImportanceSARS-CoV-2 genomes are evolving worldwide. Revealing the evolutionary characteristics of SARS-CoV-2 is essential to understand host-virus interactions. Here, we aim to understand whether mutagenesis or selection is the primary driver of SARS-CoV-2 evolution. This study provides an unbiased computational method for profiling and analyzing independently occurring SARS-CoV-2 mutations. The results point out three host antiviral mechanisms shaping the mutational profile of SARS-CoV-2 through APOBEC, ADAR, and ZAP proteins. Besides, reactive oxygen species might have an impact on the SARS-CoV-2 mutagenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2's evolutionary capacity is mostly driven by host antiviral molecules
Kieran D. Lamb, Martha M. Luka, … David L. Robertson·bioRxiv·Apr 7, 2023
- SARS-CoV-2 genome evolution exposes early human adaptations
E. S. Wright, S. S. Lakdawala, V. S. Cooper·bioRxiv·May 26, 2020
- Multi-site co-mutations and 5'UTR CpG immunity escape drive the evolution of SARS-CoV-2
- Evolution of the SARS-CoV-2 mutational spectrum
J. D. Bloom, A. C. Beichman, … K. Harris·bioRxiv·Nov 19, 2022
- Mutation rates and selection on synonymous mutations in SARS-CoV-2
N. De Maio, C. R. Walker, … N. Goldman·bioRxiv·Jan 14, 2021
- Snapshot of the evolution and mutation patterns of SARS-CoV-2
Jin Zhao, Jiumeng Sun, … Michael Veit·bioRxiv·Jul 4, 2020